Common mechanisms in immune-mediated inflammatory disease

Journal of Rheumatology

Volumn 32, Issue SUPPL. 73, 2005, Pages 8-13

  Firestein, Gary S ^a   Corr, Maripat ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cytokines; Disease models, animal; Nuclear factor kappa B; Pathogenesis; Rheumatoid arthritis; Toll like receptors

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COMPLEMENT; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; FIBRONECTIN; HEAT SHOCK PROTEIN; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; RITUXIMAB; SB 242235; SPC 839; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; GLUCOSE 6 PHOSPHATE ISOMERASE;

ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; CONFERENCE PAPER; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATORY DISEASE; MAST CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; ANIMAL; ARTHRITIS; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MOUSE; PASSIVE IMMUNIZATION; REVIEW; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; IMMUNIZATION, PASSIVE; MICE; MICE, TRANSGENIC;

EID: 13444259469     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Akira S. Toll-like receptor signaling. J Biol Chem 2003;278:38105-8.
2. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811-22.
3. Matsumoto I, Maccioni M, Lee DM, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002;3:360-5.
4. Kyburz D, Carson DA, Corr M. The role of CD40 ligand and tumor necrosis factor α signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Arthritis Rheum 2000;43:2571-7.
5. Corr M, Crain B. The role of Fc gamma R signaling in the K/BxN serum transfer model of arthritis. J Immunol 2002;169:6604-9.
6. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002;297:1689-92.
7. Ji H, Pettit A, Ohmura K, et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med 2002;196:77-85.
8. Ji H, Gauguier D, Ohmura K, et al. Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001;194:321-30.
9. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;480:740-5.
10. Choe JY, Crain B, Wu SR, Corr M. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by Toll-like receptor 4 signaling. J Exp Med 2003;4:537-42.
11. Corr M, Firestein GS. Innate immunity as a hired gun: but is it rheumatoid arthritis? J Exp Med 2002;195:F33-5.
12. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
13. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 1996;279:1453-61.
14. Badger AM, Griswold DE, Kapadia R, et al. Disease-modifying activity of SB 2422235, a selective inhibitor of p38 mitogen-activated protein kinase in rat adjuvant-induced arthritis. Arthritis Rheum 2000;43:175-83.
15. Han Z, Boyle DL, Chang L, et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001;108:73-81.
16. Han Z, Chang L, Yamanishi Y, Karin M, Firestein GS. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum 2002;46:818-23.
17. Tak PP, Firestein GS. NF-kappa B: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
18. Aupperle KR, Bennett BL, Boyle DL, Tak PP, Manning AM, Firestein GS. NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol 1999;163:427-33.
19. Tak PP, Gerlag DM, Aupperle KR, et al. Inhibitor of nuclear kappa B kinase beta is a key regulator of synovial inflammation. Arthritis Rheum 2001;44:1897-907.
20. Hammaker D, Sweeney SE, Firestein GS. Signal transduction networks in rheumatoid arthritis. Ann Rheum Dis 2003;62 Suppl 2:ii86-9.
21. Silverman GJ, Weisman S. Rituximab therapy and autoimmune diseases: prospects for anti-B cell therapy. Arthritis Rheum 2003;48:1484-92.